Cencora, Inc.'s (NYSE:COR) Executive Vice President and Chief Operating Officer, Robert P. Mauch, recently sold a significant amount of company stock, according to a new SEC filing. On April 15, Mauch sold 57,564 shares of Cencora's common stock, with the total value of the sale amounting to approximately $13,532,720. The transactions were executed at varying prices ranging from $234.17 to $236.56.
In addition to the sale, the filing also revealed that Mauch exercised options to acquire 33,877 shares of common stock at a price of $89.58 per share, totaling $3,034,701. These shares were part of a non-qualified stock option plan, with the options exercisable in four equal annual installments starting from November 14, 2019.
The sales were conducted under a Rule 10b5-1 trading plan, which Mauch had entered into on December 19, 2023. This plan allows company insiders to set up a predetermined schedule for buying and selling stocks at a time when they are not in possession of material non-public information, providing an affirmative defense against accusations of insider trading.
Following these transactions, Mauch now owns 24,412 shares of Cencora stock directly. The company, formerly known as AmerisourceBergen (NYSE:COR) Corp, is classified under the Wholesale-Drugs Proprietaries & Druggists' Sundries sector and is incorporated in Delaware.
Investors and market watchers often scrutinize insider trading activities for signals about executives’ confidence in their company's prospects. Transactions like these provide insights into insiders' perspectives and are considered material events that can influence investment decisions.
InvestingPro Insights
Amidst the news of Cencora, Inc.'s (NYSE:COR) executive selling a notable quantity of company stock, investors may be seeking additional context to gauge the company's financial health and future prospects. According to InvestingPro, Cencora has demonstrated a commitment to shareholder returns, as evidenced by its track record of raising its dividend for 19 consecutive years. This could signal confidence from management in the company's steady cash flow and long-term strategy.
Furthermore, the data reveals that Cencora has been trading at a high Price/Earnings (P/E) ratio of 25.68, suggesting that investors are willing to pay a premium for its earnings compared to the market average. This is reinforced by the adjusted P/E ratio for the last twelve months as of Q1 2024, which stands at 24.49. The company's strong free cash flow yield, as indicated by an InvestingPro Tip, supports the valuation, implying that the stock could be attractive for those looking for cash-generating investments.
InvestingPro data also highlights that Cencora's revenue growth for the last twelve months as of Q1 2024 was a robust 12.31%, with quarterly revenue growth even higher at 14.97%. Such growth rates are indicative of a company that is expanding its market presence and increasing its top-line performance.
For investors seeking more in-depth analysis, additional InvestingPro Tips are available, which provide a comprehensive look into Cencora's financial metrics, market performance, and industry standing. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription for an even more informed investment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.